BIO — Bio-Rad Laboratories Share News
0.000.00%
Last trade - 00:00- $9.85bn
- $9.39bn
- $2.58bn
Bio-Rad falls after Q1 net loss, cuts 2026 revenue outlook
U.S. RESEARCH ROUNDUP- Caterpillar, Textron, Wesco International
Bio-Rad posts Q1 net loss on Sartorius AG investment loss, cuts 2026 outlook
Brief: Bio-Rad Q1 Sales USD 592.1 Million
U.S. STOCKS ON THE MOVE-Moderna, Mohawk,
U.S. STOCKS ON THE MOVE-Moderna, Mohawk
U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, Enbridge
Bio-Rad falls after Q4 profit miss
U.S. RESEARCH ROUNDUP- Applied Materials, Humana, Gilead
Bio-Rad Q4 revenue slightly beats estimates, helped by growth in Clinical Diagnostics unit
Brief: Bio-Rad Q4 Sales USD 693.2 Million Vs. IBES Estimate USD 688.8 Million
Factbox: US companies step up job cuts amid uncertain economy
Factbox: US companies step up job cuts amid uncertain economy
Factbox: US companies step up job cuts amid uncertain economy
U.S. RESEARCH ROUNDUP- Alphabet, Boeing, KLA
Bio-Rad Q3 profit beats estimates helped by cost management
Brief: Bio-Rad Q3 Adjusted EPS USD 2.26 Vs. IBES Estimate USD 1.95
Factbox: US companies step up job cuts amid uncertain economy
Factbox: US companies announce layoffs to cut costs